Embleema Inc. announces formation of its Advisory Board.

Embleema Inc. announces the formation of its Advisory Board and the appointment of three members effective immediately: Adel B. Al-Saleh, Member of the Board of Management of Deutsche Telekom AG and CEO of T-Systems; Frédéric Duchesne, CEO of Pierre Fabre Pharmaceuticals; and Bernard Gilly, Ph.D., Founder and President of iBioNext.
“I am humbled and grateful to have Adel, Bernard and Frédéric join our Advisory Board,” said Robert Chu, Founder and CEO of Em